Remove passport-analytics
article thumbnail

SMS Lifesciences India Limited- Walk-In Interviews for R&D/ Analytical Development (AR&D)/ DQA On 3rd & 4th 2023

Pharma Pathway

Research Associate Qualification: B.Sc/ M.Sc/ B.Pharm/ M.Pharm Experience: 01 to 12 years Location: Hyderabad Note: Candidates carry Latest 3 months of Pay Slips, Resume, Education Certificates, Aadhar Card, Pan Card & UAN No, Passport photos (2) and Interested Candidates can share the resumes to admin_rnd@smslife.in

81
article thumbnail

Synokem Pharmaceuticals Ltd-Walk-In Interviews for QC/ Production/ Packing/ ADL/ IPQA/ Engineering On 18th Sept’ 2022

Pharma Pathway

ADL (Analytical Development Lab): . Qualification: M.Sc / M.Pharma (Should have sound knowledge of HPLC/ GC, Analytical Validation/ Stability studies). Please carry with your qualification, Latest Salary Slip, Passport Size Photo , and Updated Resume. Good exposer in QMS, SOP, STP Preparation. Fresher will be not Considered.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Torrent Pharmaceuticals- Walk-Ins for ADL/ F&D/ Technology Transfer On 18th Sept’ 2022

Pharma Pathway

Departments: Analytical Development Laboratory (ADL) / Formulation Technology Transfer / Formulation Development. Torrent Pharma enjoys dominance in the niche therapeutic areas like, cardiovascular and central nervous system, gastro-intestinal, pain management and oral anti-diabetic segments. Position: Executive. Experience: 01 to 08 years.

article thumbnail

Low-Priced Oncology Disruptors: The Cuckoo in the PD-1/PD-L1 Nest or the Runt of the Clutch?

pharmaphorum

It is therefore an interesting development that sugemalimab was given an Innovation Passport in NICE’s Innovative Licensing and Access Pathway (ILAP) in October 2021. We provide the analytical expertise and industry experience needed to address the industry’s toughest issues. Founded in 1965, CRA has offices throughout the world.